Mariel E. Turner MD , Tara Jones MD, PharmD , Holly Bauser-Heaton MD, PhD
{"title":"Considerations for Women with Congenital Heart Disease Undergoing Percutaneous Cardiovascular Procedures","authors":"Mariel E. Turner MD , Tara Jones MD, PharmD , Holly Bauser-Heaton MD, PhD","doi":"10.1016/j.iccl.2024.08.008","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":38721,"journal":{"name":"Interventional Cardiology Clinics","volume":"14 1","pages":"Pages 97-107"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventional Cardiology Clinics","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211745824000907","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
患有先天性心脏病的女性接受经皮心血管手术的注意事项。
为患有先天性心脏病的妇女进行导管检查有其独特的考虑因素,必须予以考虑。妊娠期继发的血流动力学变化、育龄期妇女的抗凝策略以及妊娠期对胎儿的保护都需要干预措施,而目前治疗妇女的疗法在当今时代仍然是问题多于答案。本综述重点介绍了患有先天性心脏病的妇女在接受导管治疗时所面临的一些挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。